The Latest in Hematology Times

CHMP says ponatinib’s benefits outweigh risks

October 26, 2014

FDA approves treatment for acquired hemophilia A

October 25, 2014

Insured cancer patients forgo care, scrimp to get by

October 24, 2014

Related Issues

Patients in GDR trials were not properly informed

October 24, 2014

Related Issues

Managing CNS relapse in cardiac lymphoma

October 24, 2014

Lymphoma & Plasma Cell Disorders

NICE supports use of rivaroxaban in ACS

October 24, 2014

Cancer survivors face financial, work-related issues

October 23, 2014

Collaborative cancer care cuts readmission rates

October 23, 2014

Related Issues

Supercomputers can predict drugs’ side effects

October 23, 2014

Healthcare pricing transparency may have pros and cons

October 23, 2014

Related Issues

LOY linked to higher risk of cancer, mortality in men

October 22, 2014

Related Issues

Docs often don’t know about patients’ CVCs

October 22, 2014

Related Issues

Less competition equals higher healthcare costs

October 22, 2014

Related Issues

Hospital acquisitions lead to increased patient costs

October 22, 2014

Related Issues

Enzyme ‘switch’ is key to new treatment strategy for T-ALL

October 21, 2014